Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System.

Northrup TF, Carroll K, Suchting R, Villarreal YR, Zare M, Stotts AL.

J Am Board Fam Med. 2019 May-Jun;32(3):362-374. doi: 10.3122/jabfm.2019.03.180356.

2.

A comparison of common practices for identifying substance use during pregnancy in obstetric clinics.

Klawans MR, Northrup TF, Villarreal YR, Berens PD, Blackwell S, Bunag T, Stotts AL.

Birth. 2019 Mar 27. doi: 10.1111/birt.12426. [Epub ahead of print]

PMID:
30916432
3.

Psychological Flexibility and Depression in New Mothers of Medically Vulnerable Infants: A Mediational Analysis.

Stotts AL, Villarreal YR, Klawans MR, Suchting R, Dindo L, Dempsey A, Spellman M, Green C, Northrup TF.

Matern Child Health J. 2019 Jun;23(6):821-829. doi: 10.1007/s10995-018-02699-9.

PMID:
30610529
4.

A sequential multiple assignment randomized trial for cocaine cessation and relapse prevention: Tailoring treatment to the individual.

Schmitz JM, Stotts AL, Vujanovic AA, Weaver MF, Yoon JH, Vincent J, Green CE.

Contemp Clin Trials. 2018 Feb;65:109-115. doi: 10.1016/j.cct.2017.12.015. Epub 2017 Dec 26.

5.

Family Physicians' Perceived Prevalence, Safety, and Screening for Cigarettes, Marijuana, and Electronic-Nicotine Delivery Systems (ENDS) Use during Pregnancy.

Northrup TF, Klawans MR, Villarreal YR, Abramovici A, Suter MA, Mastrobattista JM, Moreno CA, Aagaard KM, Stotts AL.

J Am Board Fam Med. 2017 Nov-Dec;30(6):743-757. doi: 10.3122/jabfm.2017.06.170183.

6.

Depression in the barrio: An analysis of the risk and protective nature of cultural values among Mexican American substance users.

Villarreal YR, Torres LR, Stotts AL, Ren Y, Sampson M, Klawans MR, Bordnick PS.

J Ethn Subst Abuse. 2019 Jan-Mar;18(1):150-164. doi: 10.1080/15332640.2017.1316222. Epub 2017 Jun 7.

PMID:
28590812
7.

An ounce of prevention: A pre-randomization protocol to improve retention in substance use disorder clinical trials.

Northrup TF, Greer TL, Walker R, Rethorst CD, Warden D, Stotts AL, Trivedi MH.

Addict Behav. 2017 Jan;64:137-142. doi: 10.1016/j.addbeh.2016.08.040. Epub 2016 Aug 31.

8.

Cognitive-behavioral therapies for depression and substance use disorders: An overview of traditional, third-wave, and transdiagnostic approaches.

Vujanovic AA, Meyer TD, Heads AM, Stotts AL, Villarreal YR, Schmitz JM.

Am J Drug Alcohol Abuse. 2017 Jul;43(4):402-415. doi: 10.1080/00952990.2016.1199697. Epub 2016 Aug 5. Review.

PMID:
27494547
9.

Impact of Physician Training on Diagnosis and Counseling of Overweight and Obese Asian Patients.

Vasudevan DA, Northrup TF, Mandayam S, Bamidele OO, Stotts AL.

J Racial Ethn Health Disparities. 2017 Jun;4(3):322-328. doi: 10.1007/s40615-016-0231-2. Epub 2016 Apr 29.

PMID:
27129859
10.

Thirdhand Smoke: State of the Science and a Call for Policy Expansion.

Northrup TF, Jacob P 3rd, Benowitz NL, Hoh E, Quintana PJ, Hovell MF, Matt GE, Stotts AL.

Public Health Rep. 2016 Mar-Apr;131(2):233-8. No abstract available.

11.

Understanding motivation to implement smoking bans among mothers with a hospitalized infant.

Stotts AL, Klawans MR, Northrup TF, Villarreal Y, Hovell MF.

Addict Behav. 2016 Jul;58:60-7. doi: 10.1016/j.addbeh.2016.02.018. Epub 2016 Feb 10.

12.
13.

A qualitative assessment of the perceived risks of electronic cigarette and hookah use in pregnancy.

Kahr MK, Padgett S, Shope CD, Griffin EN, Xie SS, Gonzalez PJ, Levison J, Mastrobattista J, Abramovici AR, Northrup TF, Stotts AL, Aagaard KM, Suter MA.

BMC Public Health. 2015 Dec 21;15:1273. doi: 10.1186/s12889-015-2586-4.

14.

Thirdhand smoke contamination in hospital settings: assessing exposure risk for vulnerable paediatric patients.

Northrup TF, Khan AM, Jacob P 3rd, Benowitz NL, Hoh E, Hovell MF, Matt GE, Stotts AL.

Tob Control. 2016 Nov;25(6):619-623. doi: 10.1136/tobaccocontrol-2015-052506. Epub 2015 Dec 3.

15.

Thirdhand Smoke in the Homes of Medically Fragile Children: Assessing the Impact of Indoor Smoking Levels and Smoking Bans.

Northrup TF, Matt GE, Hovell MF, Khan AM, Stotts AL.

Nicotine Tob Res. 2016 May;18(5):1290-8. doi: 10.1093/ntr/ntv174. Epub 2015 Aug 26.

16.

Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: a discrete survival and growth mixture model.

Northrup TF, Stotts AL, Green C, Potter JS, Marino EN, Walker R, Weiss RD, Trivedi M.

Addict Behav. 2015 Feb;41:20-8. doi: 10.1016/j.addbeh.2014.09.021. Epub 2014 Sep 28.

17.

The role of avoidance and inflexibility in characterizing response to contingency management for cocaine use disorders: A secondary profile analysis.

Stotts AL, Vujanovic A, Heads A, Suchting R, Green CE, Schmitz JM.

Psychol Addict Behav. 2015 Jun;29(2):408-13. doi: 10.1037/adb0000011. Epub 2014 Aug 18.

PMID:
25134057
18.

Randomized, controlled pilot trial of bupropion for pregnant smokers: challenges and future directions.

Stotts AL, Northrup TF, Cinciripini PM, Minnix JA, Blalock JA, Mullen PD, Pedroza C, Blackwell S.

Am J Perinatol. 2015 Mar;32(4):351-6. doi: 10.1055/s-0034-1386635. Epub 2014 Aug 11.

19.

Characteristics associated with intervention and follow-up attendance in a secondhand smoke exposure study for families of NICU infants.

Northrup TF, Green C, Evans PW, Stotts AL.

J Matern Fetal Neonatal Med. 2015 Jul;28(10):1208-13. doi: 10.3109/14767058.2014.947950. Epub 2014 Aug 14.

PMID:
25053191
20.

Families at risk: home and car smoking among pregnant women attending a low-income, urban prenatal clinic.

Stotts AL, Northrup TF, Hutchinson MS, Pedroza C, Blackwell SC.

Nicotine Tob Res. 2014 Jul;16(7):1020-5. doi: 10.1093/ntr/ntu049. Epub 2014 Apr 1.

21.

A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone.

Schmitz JM, Green CE, Stotts AL, Lindsay JA, Rathnayaka NS, Grabowski J, Moeller FG.

Drug Alcohol Depend. 2014 Mar 1;136:100-7. doi: 10.1016/j.drugalcdep.2013.12.015. Epub 2014 Jan 3.

22.

Breastfeeding practices in mothers of high-respiratory-risk NICU infants: impact of depressive symptoms and smoking.

Northrup TF, Wootton SH, Evans PW, Stotts AL.

J Matern Fetal Neonatal Med. 2013 Dec;26(18):1838-43. doi: 10.3109/14767058.2013.805195. Epub 2013 Jun 20.

PMID:
23672205
23.

Feasibility and efficacy of an intervention to reduce secondhand smoke exposure among infants discharged from a neonatal intensive care unit.

Stotts AL, Green C, Northrup TF, Dodrill CL, Evans P, Tyson J, Velasquez M, Hammond SK, Hovell MF.

J Perinatol. 2013 Oct;33(10):811-6. doi: 10.1038/jp.2013.43. Epub 2013 Apr 25.

PMID:
23619375
24.

Baby's Breath II protocol development and design: a secondhand smoke exposure prevention program targeting infants discharged from a neonatal intensive care unit.

Stotts AL, Northrup TF, Schmitz JM, Green C, Tyson J, Velasquez MM, Khan A, Hovell MF.

Contemp Clin Trials. 2013 May;35(1):97-105. doi: 10.1016/j.cct.2013.02.012. Epub 2013 Mar 1.

25.

Depression among mothers of high-risk infants discharged from a neonatal intensive care unit.

Northrup TF, Evans PW, Stotts AL.

MCN Am J Matern Child Nurs. 2013 Mar;38(2):89-94. doi: 10.1097/NMC.0b013e318270f8b8.

PMID:
23426050
26.

A stage I pilot study of acceptance and commitment therapy for methadone detoxification.

Stotts AL, Green C, Masuda A, Grabowski J, Wilson K, Northrup TF, Moeller FG, Schmitz JM.

Drug Alcohol Depend. 2012 Oct 1;125(3):215-22. doi: 10.1016/j.drugalcdep.2012.02.015. Epub 2012 Mar 15.

27.

Secondhand smoke risk in infants discharged from an NICU: potential for significant health disparities?

Stotts AL, Evans PW, Green CE, Northrup TF, Dodrill CL, Fox JM, Tyson JE, Hovell MF.

Nicotine Tob Res. 2011 Nov;13(11):1015-22. doi: 10.1093/ntr/ntr116. Epub 2011 Jun 13.

28.

Comparison of BMI and anthropometric measures among South Asian Indians using standard and modified criteria.

Vasudevan D, Stotts AL, Mandayam S, Omegie LA.

Public Health Nutr. 2011 May;14(5):809-16. doi: 10.1017/S1368980010003307. Epub 2011 Jan 20.

PMID:
21247513
29.

Contingency management and levodopa-carbidopa for cocaine treatment: a comparison of three behavioral targets.

Schmitz JM, Lindsay JA, Stotts AL, Green CE, Moeller FG.

Exp Clin Psychopharmacol. 2010 Jun;18(3):238-44. doi: 10.1037/a0019195.

30.

Effects of an intensive depression-focused intervention for smoking cessation in pregnancy.

Cinciripini PM, Blalock JA, Minnix JA, Robinson JD, Brown VL, Lam C, Wetter DW, Schreindorfer L, McCullough JP, Dolan-Mullen P, Stotts AL, Karam-Hage M.

J Consult Clin Psychol. 2010 Feb;78(1):44-54. doi: 10.1037/a0018168.

31.

High-dose naltrexone therapy for cocaine-alcohol dependence.

Schmitz JM, Lindsay JA, Green CE, Herin DV, Stotts AL, Moeller FG.

Am J Addict. 2009 Sep-Oct;18(5):356-62. doi: 10.3109/10550490903077929.

32.

Ultrasound feedback and motivational interviewing targeting smoking cessation in the second and third trimesters of pregnancy.

Stotts AL, Groff JY, Velasquez MM, Benjamin-Garner R, Green C, Carbonari JP, DiClemente CC.

Nicotine Tob Res. 2009 Aug;11(8):961-8. doi: 10.1093/ntr/ntp095. Epub 2009 Jun 24.

33.

Opioid dependence treatment: options in pharmacotherapy.

Stotts AL, Dodrill CL, Kosten TR.

Expert Opin Pharmacother. 2009 Aug;10(11):1727-40. doi: 10.1517/14656560903037168. Review.

34.

Cocaine dependence and concurrent marijuana use: a comparison of clinical characteristics.

Lindsay JA, Stotts AL, Green CE, Herin DV, Schmitz JM.

Am J Drug Alcohol Abuse. 2009;35(3):193-8. doi: 10.1080/00952990902933860.

35.
36.

Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform.

Schmitz JM, Mooney ME, Moeller FG, Stotts AL, Green C, Grabowski J.

Drug Alcohol Depend. 2008 Apr 1;94(1-3):142-50. doi: 10.1016/j.drugalcdep.2007.11.004. Epub 2007 Dec 27.

37.

Bupropion and cognitive-behavioral therapy for smoking cessation in women.

Schmitz JM, Stotts AL, Mooney ME, Delaune KA, Moeller GF.

Nicotine Tob Res. 2007 Jun;9(6):699-709. Erratum in: Nicotine Tob Res. 2007 Jul;9(7):785.

PMID:
17558827
38.

Illusory predictors: Generalizability of findings in cocaine treatment retention research.

Stotts AL, Mooney ME, Sayre SL, Novy M, Schmitz JM, Grabowski J.

Addict Behav. 2007 Dec;32(12):2819-36. Epub 2007 May 3. Review.

39.

Preliminary feasibility and efficacy of a brief motivational intervention with psychophysiological feedback for cocaine abuse.

Stotts AL, Potts GF, Ingersoll G, George MR, Martin LE.

Subst Abus. 2006 Dec;27(4):9-20.

PMID:
17347121
40.

Adding MEMS feedback to behavioral smoking cessation therapy increases compliance with bupropion: a replication and extension study.

Mooney ME, Sayre SL, Hokanson PS, Stotts AL, Schmitz JM.

Addict Behav. 2007 Apr;32(4):875-80. Epub 2006 Jul 12.

PMID:
16839698
41.

Medication compliance during a smoking cessation clinical trial: a brief intervention using MEMS feedback.

Schmitz JM, Sayre SL, Stotts AL, Rothfleisch J, Mooney ME.

J Behav Med. 2005 Apr;28(2):139-47.

PMID:
15957569
42.

Impact of a motivational intervention on mechanisms of change in low-income pregnant smokers.

Stotts AL, DeLaune KA, Schmitz JM, Grabowski J.

Addict Behav. 2004 Nov;29(8):1649-57.

PMID:
15451133
43.

Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy.

Schmitz JM, Stotts AL, Sayre SL, DeLaune KA, Grabowski J.

Am J Addict. 2004 Jul-Sep;13(4):333-41.

PMID:
15370932
44.

"Who gets in?" Recruitment and screening processes of outpatient substance abuse trials.

Sayre SL, Evans M, Hokanson PS, Schmitz JM, Stotts AL, Averill P, Grabowski J.

Addict Behav. 2004 Feb;29(2):389-98.

PMID:
14732428
45.

Tobacco, alcohol and caffeine use in a low-income, pregnant population.

Stotts AL, Shipley SL, Schmitz JM, Sayre SL, Grabowski J.

J Obstet Gynaecol. 2003 May;23(3):247-51.

PMID:
12850852
46.

Concurrent treatment for alcohol and tobacco dependence: are patients ready to quit both?

Stotts AL, Schmitz JM, Grabowski J.

Drug Alcohol Depend. 2003 Jan 24;69(1):1-7.

PMID:
12536060
47.

Determining predictors of attrition in an outpatient substance abuse program.

Sayre SL, Schmitz JM, Stotts AL, Averill PM, Rhoades HM, Grabowski JJ.

Am J Drug Alcohol Abuse. 2002;28(1):55-72.

PMID:
11853135
48.

One-to-one: a motivational intervention for resistant pregnant smokers.

Stotts AL, Diclemente CC, Dolan-Mullen P.

Addict Behav. 2002 Mar-Apr;27(2):275-92.

PMID:
11817768
49.

Motivational interviewing with cocaine-dependent patients: a pilot study.

Stotts AL, Schmitz JM, Rhoades HM, Grabowski J.

J Consult Clin Psychol. 2001 Oct;69(5):858-62.

PMID:
11680565
50.

Fluoxetine treatment of cocaine-dependent patients with major depressive disorder.

Schmitz JM, Averill P, Stotts AL, Moeller FG, Rhoades HM, Grabowski J.

Drug Alcohol Depend. 2001 Aug 1;63(3):207-14.

PMID:
11418225

Supplemental Content

Loading ...
Support Center